434 related articles for article (PubMed ID: 10400908)
1. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase.
Feron O; Dessy C; Moniotte S; Desager JP; Balligand JL
J Clin Invest; 1999 Mar; 103(6):897-905. PubMed ID: 10079111
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions.
Feron O; Michel JB; Sase K; Michel T
Biochemistry; 1998 Jan; 37(1):193-200. PubMed ID: 9425039
[TBL] [Abstract][Full Text] [Related]
4. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.
Lungu AO; Jin ZG; Yamawaki H; Tanimoto T; Wong C; Berk BC
J Biol Chem; 2004 Nov; 279(47):48794-800. PubMed ID: 15383526
[TBL] [Abstract][Full Text] [Related]
6. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae.
Shaul PW; Smart EJ; Robinson LJ; German Z; Yuhanna IS; Ying Y; Anderson RG; Michel T
J Biol Chem; 1996 Mar; 271(11):6518-22. PubMed ID: 8626455
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells.
Feron O; Belhassen L; Kobzik L; Smith TW; Kelly RA; Michel T
J Biol Chem; 1996 Sep; 271(37):22810-4. PubMed ID: 8798458
[TBL] [Abstract][Full Text] [Related]
8. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production.
Heijnen HF; Waaijenborg S; Crapo JD; Bowler RP; Akkerman JW; Slot JW
J Histochem Cytochem; 2004 Oct; 52(10):1277-85. PubMed ID: 15385574
[TBL] [Abstract][Full Text] [Related]
10. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association.
Rizzo V; McIntosh DP; Oh P; Schnitzer JE
J Biol Chem; 1998 Dec; 273(52):34724-9. PubMed ID: 9856995
[TBL] [Abstract][Full Text] [Related]
11. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
Feron O; Dessy C; Desager JP; Balligand JL
Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase and its negative regulator caveolin-1 localize to distinct perinuclear organelles.
Govers R; van der Sluijs P; van Donselaar E; Slot JW; Rabelink TJ
J Histochem Cytochem; 2002 Jun; 50(6):779-88. PubMed ID: 12019294
[TBL] [Abstract][Full Text] [Related]
13. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling.
García-Cardeña G; Oh P; Liu J; Schnitzer JE; Sessa WC
Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6448-53. PubMed ID: 8692835
[TBL] [Abstract][Full Text] [Related]
14. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.
Uittenbogaard A; Shaul PW; Yuhanna IS; Blair A; Smart EJ
J Biol Chem; 2000 Apr; 275(15):11278-83. PubMed ID: 10753938
[TBL] [Abstract][Full Text] [Related]
15. The endothelial nitric-oxide synthase-caveolin regulatory cycle.
Feron O; Saldana F; Michel JB; Michel T
J Biol Chem; 1998 Feb; 273(6):3125-8. PubMed ID: 9452418
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells.
Schwartz EA; Reaven E; Topper JN; Tsao PS
Biochem J; 2005 Aug; 390(Pt 1):199-206. PubMed ID: 15819614
[TBL] [Abstract][Full Text] [Related]
18. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
Blair A; Shaul PW; Yuhanna IS; Conrad PA; Smart EJ
J Biol Chem; 1999 Nov; 274(45):32512-9. PubMed ID: 10542298
[TBL] [Abstract][Full Text] [Related]
19. Targeting and translocation of endothelial nitric oxide synthase.
Michel T
Braz J Med Biol Res; 1999 Nov; 32(11):1361-6. PubMed ID: 10559837
[TBL] [Abstract][Full Text] [Related]
20. Reduced caveolae density in arteries of SHR contributes to endothelial dysfunction and ROS production.
Potje SR; Grando MD; Chignalia AZ; Antoniali C; Bendhack LM
Sci Rep; 2019 Apr; 9(1):6696. PubMed ID: 31040342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
